Product Images Topotecan

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Topotecan NDC 16729-243 by Accord Healthcare Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 2 - topotecan 1 mg per ml carton

image 2 - topotecan 1 mg per ml carton

This appears to be a label or instruction sheet for a medication in vial form. It includes information on dilution requirements, intravenous infusion, cautionary notes about cytotoxic agents, and mention of lot and expiration information for the product. The text also references a 2D matrix and measurements for an unvarnished area for pasting.*

image 1 - topotecan 1 mg per ml container label

image 1 - topotecan 1 mg per ml container label

TOPPOLECAN Injection is a cytotoxic agent that requires careful handling and a review of the package insert for administration protocols. The typical dosage is 1mg/mL, and the medication should be stored between 20°C to 25°C while being protected from light. The medication must be diluted before use and should be used within 28 days of opening. This medication is only available through prescription, and it is produced in India by Accord Healthcare.*

image 4 - topotecan 4 mg per 4 ml carton

image 4 - topotecan 4 mg per 4 ml carton

Description not available.*

image 3 - topotecan 4 mg per 4 ml container label

image 3 - topotecan 4 mg per 4 ml container label

This is a description for a medication named "Topotecan Injection SRS". The medication comes in a 4mL multiple-dose vial that must be stored at 20°C to 25°C (68°F to 77°F). The medication is a cytotoxic agent and must be used within 28 days after the first use. The vial must be protected from light and retained in the carton. For details on dosage, refer to the insert. The rest of the text contains information unrelated to the medication, and it is not available what it is about.*

figure 10 - topotecan graph1

figure 10 - topotecan graph1

This is a comparison between Topotecan Injection plus Cisplatin and Cisplatin Monotherapy in a study that lasted for some months. No further information is available from the given text.*

structural formula - topotecan structure

structural formula - topotecan structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.